Search
Close this search box.

September 5, 2023

Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia

Collaboration furthers Zenas’ vision to bring innovative immunology-based medicines to patients around the world by leveraging Bristol Myers Squibb’s long-standing expertise in immune-mediated diseases Zenas will receive a $50 million up-front cash payment and an equity investment from Bristol Myers

Read More

William Ruto: Africa can meet all energy needs

The President of Kenya, William Ruto, highlighted this Monday, in Nairobi, the potential of Africa’s renewable resources that can supply all of the continent’s energy needs.“The continent has enough potential to be fully self-sufficient with the combin…

Read More

African summit outlines new funding architecture

African countries are to outline, this Tuesday, in Nairobi, Kenya, a new climate finance architecture, after defaults by industrialized countries.In the high-level segment of the African Climate Summit, which brings together Heads of State and Governme…

Read More

Pages